Insmed Incorporated - Common Stock (INSM)
77.21
+0.92 (1.21%)
Insmed Inc is a biopharmaceutical company focused on the development and commercialization of innovative therapies for patients with serious and rare diseases
The company specializes in creating treatments for conditions related to severe respiratory infections, particularly those caused by non-tuberculous mycobacteria. Insmed’s research and development efforts are driven by a commitment to address unmet medical needs, utilizing advanced science and technology to bring forward new options for patients who often have limited alternatives. Through their clinical programs, Insmed aims to improve health outcomes and enhance the quality of life for individuals suffering from these challenging conditions.
| Previous Close | 76.29 |
|---|---|
| Open | 75.46 |
| Bid | 75.86 |
| Ask | 80.80 |
| Day's Range | 74.67 - 78.41 |
| 52 Week Range | 21.92 - 84.91 |
| Volume | 4,652,730 |
| Market Cap | 8.90B |
| PE Ratio (TTM) | -13.86 |
| EPS (TTM) | -5.6 |
| Dividend & Yield | N/A (N/A) |
| 1 Month Average Volume | 2,044,772 |
